4-methoxy-2-methyl-benzofuran-6-carboxylic acid | 37963-75-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-methoxy-2-methyl-benzofuran-6-carboxylic acid
• 英文别名: 4-Methoxy-2-methylbenzofuran-6-carboxylic acid；4-methoxy-2-methyl-1-benzofuran-6-carboxylic acid
• CAS: 37963-75-0
• 化学式: C₁₁H₁₀O₄
• 分子量: 206.198
• InChiKey: KFRZWELTSUOOAL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  59.7
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• TERTIARY AMIDES AND METHOD OF USE
  申请人：AbbVie Inc.

  公开号：US20190119200A1

  公开（公告）日：2019-04-25

  Compounds of Formula (I) and pharmaceutically acceptable salts thereof, wherein G 1 , G 2 , G 3 , L 1 , L 2 , and L 3 are as defined in the specification, are useful in treating conditions or disorders prevented by or ameliorated by the modulation of lysophosphatidic acid receptor 1. Methods for making the compounds are described. Also described are pharmaceutical compositions of compounds of formula (I), and methods for using such compounds and compositions.
• [EN] TERTIARY AMIDES AND METHOD OF USE<br/>[FR] AMIDES TERTIAIRES ET PROCÉDÉ D'UTILISATION
  申请人：ABBVIE INC

  公开号：WO2017177004A1

  公开（公告）日：2017-10-12

  Compunds of Formula (I) and pharmaceutically acceptable salts thereof, wherein G1, G2, G3, L1, L2, and L3 are as defined in the specification, are useful in treating conditions or disorders prevented by or ameliorated by the modulation of lysophosphatidic acid receptor 1. Methods for making the compounds are described. Also described are pharmaceutical compositions of compounds of formula (I), and methods for using such compounds and compositions.